The first clinical trial, titled A Phase 2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of BG00012 in Combination with Methotrexate in Patients with Active RA Who Have Inadequate Response to Conventional Disease-Modifying Anti-Rheumatic Drug Therapy (NCT00810836, 20012010), was initiated by Biogen and involved 153 participants
Cloudiness, haziness, or any visible particles are definitive signs of contamination
Deep phenotyping of myalgic encephalomyelitis/chronic fatigue syndrome in Japanese population
Aging adults experiencing a decline in muscle mass or strength
IL-23 induces receptor activator of NF-B ligand expression in fibroblast-like synoviocytes via STAT3 and NF-B signal pathways